Comparative Persistency with Newer agents used to Treat...

Value in Health 2015 / 05 Vol. 18; Iss. 3

Comparative Persistency with Newer agents used to Treat Type 2 Diabetes (T2dm) In the united states: canagliflozin Versus Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors and Glucagon-Like Peptide-1 (Glp-1) agonists

Diels, J., Neslusan, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.03.398
Date:
May, 2015
File:
PDF, 68 KB
english, 2015
Conversion to is in progress
Conversion to is failed